Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
367 Suppl
pubmed:dateCreated
1999-11-18
pubmed:abstractText
alpha-BSM is a biomimetic endothermically setting apatitic calcium phosphate bone substitute material. Its injectability and ability to harden at body temperature in the presence of physiologic saline, and other buffering agents, makes it an attractive clinical bone substitute and delivery vehicle for therapeutic agents in orthopaedic and dental applications. In osseous tissue, alpha-BSM alone remodels into bone and promotes bone healing. alpha-BSM treatment has been shown in several animal models to be effective in promoting healing of surgically created critical size defects and restoring bone biomechanical strength to values equal to or greater than values achieved with autograft controls. In vitro studies with alpha-BSM containing gentamicin show that antibiotics can be incorporated stably into alpha-BSM and that the release kinetics can be controlled with the appropriate formulation and preparative procedures. Growth factors and enzymes also are compatible with the alpha-BSM setting reaction. The incorporation of recombinant human bone morphogenetic protein-2 with alpha-BSM was shown to be effective in stimulating bone formation and accelerating restoration of the differentiated phenotype in an osteotomy model. Clinical trial investigators in Europe currently are using alpha-BSM implantations for treatment of fractures and other indications.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/BMP2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 2, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Bone Substitutes, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Phosphates, http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers, http://linkedlifedata.com/resource/pubmed/chemical/Gentamicins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/alpha-tricalcium phosphate, http://linkedlifedata.com/resource/pubmed/chemical/calcium phosphate, http://linkedlifedata.com/resource/pubmed/chemical/dicalcium phosphate anhydrous, http://linkedlifedata.com/resource/pubmed/chemical/monocalcium phosphate, http://linkedlifedata.com/resource/pubmed/chemical/tetracalcium phosphate
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0009-921X
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S396-405
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10546662-Animals, pubmed-meshheading:10546662-Anti-Bacterial Agents, pubmed-meshheading:10546662-Biomechanics, pubmed-meshheading:10546662-Bone Morphogenetic Protein 2, pubmed-meshheading:10546662-Bone Morphogenetic Proteins, pubmed-meshheading:10546662-Bone Substitutes, pubmed-meshheading:10546662-Bone and Bones, pubmed-meshheading:10546662-Calcium Phosphates, pubmed-meshheading:10546662-Dogs, pubmed-meshheading:10546662-Drug Carriers, pubmed-meshheading:10546662-Female, pubmed-meshheading:10546662-Femur, pubmed-meshheading:10546662-Gentamicins, pubmed-meshheading:10546662-Male, pubmed-meshheading:10546662-Prostheses and Implants, pubmed-meshheading:10546662-Rabbits, pubmed-meshheading:10546662-Radius, pubmed-meshheading:10546662-Recombinant Proteins, pubmed-meshheading:10546662-Transforming Growth Factor beta, pubmed-meshheading:10546662-Wound Healing
pubmed:year
1999
pubmed:articleTitle
alpha-BSM: a biomimetic bone substitute and drug delivery vehicle.
pubmed:affiliation
ETEX Corporation, University Park MIT, Cambridge, MA 02139, USA.
pubmed:publicationType
Journal Article, In Vitro